Human medicines European public assessment report (EPAR): Pritor, telmisartan, Revision: 28, Authorised

06:10 EDT 26 Apr 2018 | European Medicines Agency

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Pritor, telmisartan, Revision: 28, Authorised"